30 results
8-K
EX-99.1
DAWN
Day One Biopharmaceuticals, Inc.
24 Apr 24
Regulation FD Disclosure
8:01am
) working groups and the patients and families impacted by a pLGG diagnosis, the way we think about measuring response and the goals of therapy
8-K
EX-99.1
ohc0m8k13g uw2
8 Jan 24
Regulation FD Disclosure
8:30am
S-8
EX-99.1
w4slipj9
4 Jan 24
Registration of securities for employees
4:06pm
PRE 14A
ft1ndgqe09 haxh0
18 Apr 23
Preliminary proxy
4:05pm
S-8
EX-99.1
kskd39 8jq
31 Oct 22
Registration of securities for employees
4:07pm
424B5
o0lxs8q0x4ad
16 Jun 22
Prospectus supplement for primary offering
7:30am
424B5
g2ykpnf
14 Jun 22
Prospectus supplement for primary offering
7:39am
DEF 14A
ut3 8v9d67
28 Apr 22
Definitive proxy
4:44pm